A-Derma Exomega Control Emollient Cream airless pump bottle
Supporting role for Eczema
What Makes This Different

The cream formulation makes the Exomega Control active set — Rhealba oat, sunflower oil unsaponifiables, niacinamide — usable year-round on a wider range of atopic-prone skin types than the heavier balm. For users in temperate climates or who need a less occlusive option, this is the more practical daily choice.

A-Derma

A-Derma Exomega Control Emollient Cream Review

Daily Atopic Companion
body care cream pharmacy brand Paraben Free Cruelty Free

The lighter sibling of A-Derma's Exomega Control balm — same Rhealba oat, sunflower oil unsaponifiables, and niacinamide active set, in a cream base that works better for year-round daily use and milder atopic-prone skin. For most adult users and for summer routines, this is the more practical choice of the two Exomega variants.

$26.00
200ml · other sizes available
4.5
1,600 reviews
Made in France Launched 2017 All-year use PAO: 12 months
Buy at Amazon
Verdicts

How well it fits each concern

Verdict by concern tap a concern for the case

Supporting rolefor EczemaNiacinamide has early evidence for eczema, and emollient therapy is the recognised companion to treating it — a reasonable supporting choice, short of a recommendation.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Niacinamide has early or mechanistic evidence for this concern, not trial-backed standing.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Supporting role” is the verdict on 7,003 of 38,141 concern verdicts across the catalog; rule R8a decided 1,310 of them. Unchanged since September 5, 2026, engine 5.1.1. Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R8a — A plausible-tier active in a category with a supportive job: the sentence names the active instead of saying nothing targets the concern (the AmLactin / CeraVe SA case for keratosis pilaris, where no guideline and single trials leave the keratolytics at early evidence). · the full register
Carrying active
Niacinamide
Standing
plausible — trials support it
Form
plausible
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
All eczema products →
Good choicefor DrynessShea Butter is a reference standard by mechanism for dryness; this cream carries it.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Shea Butter has trial-supported standing for this concern.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 7,957 of 38,141 concern verdicts across the catalog; rule R5 decided 7,535 of them. Unchanged since September 5, 2026, engine 5.1.1. Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Shea Butter
Standing
supported — its mechanism is established
Form
plausible — studied range 1–100%, from the trials on the row; needs leave-on contact
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)

The studies behind the evidence row

  • International Cosmetic Ingredient Dictionary and Handbook — declared function — Personal Care Products Council
  • Harry's Cosmeticology / Baran & Maibach Textbook of Cosmetic Dermatology — humectant, emollient and occlusive classification — standard reference text
All dryness products →
Good choicefor SensitivityNo fragrance, drying alcohol, declarable allergens or sensitising preservatives in this cream — the profile sensitive skin looks for.Not yet assessedGentleNo reviews collected yet

The case for it

  1. Rhealba Oat Extract has no evidence row yet for this concern — it is in the research queue.
  2. The formula carries none of the triggers this concern is sensitive to.

What would change this: A researched evidence row for the lead active would replace this with a verdict.

Same rule for everyone. “Good choice” is the verdict on 1,681 of 38,141 concern verdicts across the catalog; rule F2 decided 1,681 of them. Unchanged since September 5, 2026, engine 5.1.1. Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
F2 — Gentle = no weighted deduction fired and fit ≥ 90. · the full register
Carrying active
Rhealba Oat Extract
Standing
not assessed
Form
plausible
Tolerability
gentle
All sensitivity products →
Good choicefor Compromised Skin BarrierNiacinamide is a reference standard by mechanism for compromised skin barrier; this cream carries it.Moderate evidenceGentleNo reviews collected yet

The case for it

  1. Niacinamide has trial-supported standing for this concern.
  2. It is plausibly present at a working level, though the concentration is not declared.
  3. The formula carries none of the triggers this concern is sensitive to.

What would change this: A declared concentration would move this to a firmer reading of the dose.

Same rule for everyone. “Good choice” is the verdict on 7,957 of 38,141 concern verdicts across the catalog; rule R5 decided 7,535 of them. Unchanged since September 5, 2026, engine 5.1.1. Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R5 — Trial-supported or guideline-supported active, adequately or plausibly dosed. · the full register
Carrying active
Niacinamide
Standing
supported — its mechanism is established
Form
plausible — studied range 2%, from the trials on the row; needs leave-on contact; judge it after ~8 weeks
Tolerability
gentle
Row checked
against its sources on July 17, 2026 (evidence table ev-2026.09-r228)
All compromised skin barrier products →
Supporting rolefor Keratosis PilarisNothing here targets keratosis pilaris directly; emollient hydration is the recognised companion to treating it, and this cream does that without known triggers.Not yet assessedGentleNo reviews collected yet

The case for it

  1. Rhealba Oat Extract has no evidence row yet for this concern — it is in the research queue.
  2. The formula carries none of the triggers this concern is sensitive to.

What would change this: A researched evidence row for the lead active would replace this with a verdict.

Same rule for everyone. “Supporting role” is the verdict on 7,003 of 38,141 concern verdicts across the catalog; rule R8 decided 3,540 of them. Unchanged since September 5, 2026, engine 5.1.1. Brand or formulator? Disclose a concentration or correct a fact →

Show the work
Rule
R8 — The category's job (barrier care, humectant hydration, gentle cleansing, photoprotection) is the documented supportive role for this concern. This is the honest verdict for a moisturizer on an acne page. · the full register
Carrying active
Rhealba Oat Extract
Standing
not assessed
Form
plausible
Tolerability
gentle
All keratosis pilaris products →

As a body productNot judged: what a body product is for — real substance, not just slip, realistic to use daily — cannot yet be measured from the ingredient list (only fragrance load can).

A verdict is DermApproved’s assessment of how well a product’s ingredients fit a concern — never a claim about what the product treats. Evidence dots and collected reviews sit beside it and are never blended in. Rules 0.5.1 · evidence table ev-2026.09-r228 · how we decide

Assessment

Pros & Cons

Pros

  • Same evidence-backed active set as the Exomega Control balm
  • Lighter cream texture suited to year-round daily use
  • Absorbs in about a minute into a non-greasy finish
  • Safe for atopic-prone children and adults across ages
  • AFPADA atopic skin recommendation
  • Pairs well with prescription eczema treatments
  • Better suited to warmer climates than the balm variant

Cons

  • Insufficient for severely dry atopic-prone skin in deep winter
  • Less occlusive than the balm for nighttime sealing
  • Price is higher than drugstore equivalents
  • Does not replace prescription treatment during active flares
  • Limited US retail distribution compared to European markets
Review

Full Review

Once a dermatologist has explained that the best thing you can do for atopic-prone skin is apply a moisturizer twice a day, every day, head to toe, the next question is not which product has the fanciest ingredients — it's which one you'll actually use that faithfully for the next twelve months. Adherence is the unglamorous determinant of outcome in atopic skin management. A balm that's too heavy for your climate gets skipped in summer. A cream that's too light for your winter skin gets replaced with something heavier and then you forget to buy another bottle and you're back to zero. The Exomega Control Cream exists because A-Derma's pediatric dermatology partners asked the brand for a lighter version of the Exomega balm that would survive the 'daily use for a year' test across a wider range of atopic users and seasons.

The formula is the cream-textured sibling of the Exomega Control Emollient Balm reviewed elsewhere in this database. It contains the same core active ingredient set: Rhealba oat extract as the anti-inflammatory foundation, sunflower oil unsaponifiables as the essential-fatty-acid replenishment, niacinamide as the endogenous ceramide-synthesis driver, and shea butter as the emollient backbone. What's different is the ratio of water to lipids and the choice of emollient esters — this version uses caprylic/capric triglyceride instead of mineral oil for the core emollient, giving it a lighter slip and faster absorption without sacrificing the core repair mechanism. The rest of the list is short and purposeful: glycerin, propanediol and pentylene glycol carry the water phase, cetearyl alcohol and glyceryl stearate give the cream its structure, a small amount of dimethicone smooths the finish, meadowsweet extract adds a second quiet anti-irritant note, and tocopherol protects the plant lipids from going rancid in a bottle that will sit open on a bathroom shelf for a month. Eighteen ingredients, no fragrance, no essential oils, no botanical decoration. For a category where reactive skin punishes every unnecessary addition, the restraint is the point.

On application, the cream feels soft and cushiony rather than occlusive. It spreads easily, sinks in without effort, and leaves skin feeling comforted rather than coated. The airless pump means you can dispense it one-handed onto a wet forearm without contaminating the bottle, which sounds trivial until you're doing it twice a day for a year. This matters for a lot of real-world atopic-prone users who find the balm either too rich for summer or too heavy for the body areas they need to moisturize daily. For adults with mild to moderate atopic-prone skin on arms, legs, and torso, the cream is often the more realistic daily choice. For kids who kick off sheets and can't tolerate a heavier product on bare skin, the cream is easier to work with. For year-round use in temperate climates, it's the sibling that actually fits into the routine. The balm, for all its quality, has a slightly narrower use case — severe winter dryness, severely dry atopic-prone patches, and cold-climate daily use.

The performance over weeks of consistent use is what actually matters, and here the cream and the balm converge. Skin feels soft and untight from the first application; itch and baseline dryness settle over the first week or two; and the payoff most people are actually after — fewer flares, and milder ones — shows up somewhere in the four-to-eight-week window, which is precisely why the daily protocol is a protocol and not a suggestion. The cream may take slightly longer to achieve the same visible smoothness on extremely dry patches — the balm is still the better choice for the worst skin — but for the majority of atopic-prone users, the cream is functionally equivalent and practically superior. The niacinamide driving endogenous ceramide synthesis doesn't care about the texture of its delivery vehicle, the sunflower oil unsaponifiables provide the same essential fatty acids either way, and the Rhealba oat is anti-inflammatory at the concentrations used in both products. The idea that a lighter cream can't handle eczema-prone skin has the biology backwards: occlusion is only one lever, and a formula that gets applied is doing more than a richer one drying out in a cupboard. It's also quietly useful on the pebbled upper arms of keratosis pilaris, where lipid replacement and gentle anti-inflammatory support do more than aggressive scrubbing.

Its weak points are few and minor. For severely dry atopic-prone skin in deep winter, this cream will not be enough on its own — layer a heavier balm on top of the worst patches at night, or switch to the balm version during the coldest months and keep the cream for warmer weather. The 200ml bottle runs out in four to six weeks of daily full-body use, and a 400ml size exists in some markets that's meaningfully better value for a household doing this properly. The fatty content also means it isn't a fungal-acne-safe choice for the chest and back. And like the balm, this cream is a supportive rather than treatment product — it reduces flare frequency and severity, but it does not replace prescription treatment for active flares. Where a topical steroid or calcineurin inhibitor is in play, that goes on first, absorbs, and the cream goes over the top.

What the Exomega Control Cream gets right is the match between formulation and adherence. The clinical evidence for daily emollient use in atopic-prone skin depends entirely on whether users actually apply the product every day. A well-formulated cream that feels pleasant enough to use twice a day for a year will produce better outcomes than a slightly more intensive product that gets skipped every third day. The steady trickle of reviews saying much the same thing — lighter than the balm, still works, easy to keep using — is the strongest evidence you'll get that the calibration landed. It does enough to matter, and it's light enough to get used, and the combination is where its value lives.

Formula

Key Ingredients

The hero actives that drive this product's performance.

IngredientFunctionEvidence
Rhealba Oat Extract Delivers the anti-inflammatory activity that the entire Exomega line relies on, working to quiet the low-grade inflammation that drives atopic skin between flares. Not yet assessed
Sunflower Oil Unsaponifiables Provides linoleic acid and other essential fatty acids that atopic-prone skin is metabolically short on; this is one of the more biologically targeted choices in the formula. Not yet assessed
Niacinamide Drives endogenous ceramide synthesis, which means this cream supports the skin's own barrier rebuilding rather than just sitting on top of it — an important functional difference from simple occlusive moisturizers. Established mechanism for Compromised Skin Barrier · established mechanism
Shea Butter Contributes the emollient backbone in a lighter ratio than the Exomega balm — this cream is calibrated for warmer-weather and year-round daily use where the balm's full weight isn't needed. Established mechanism for Dryness · established mechanism
Full INCI List

Aqua, Glycerin, Caprylic/Capric Triglyceride, Propanediol, Pentylene Glycol, Butyrospermum Parkii Butter, Avena Rhealba Extract, Helianthus Annuus Seed Oil Unsaponifiables, Niacinamide, Cetearyl Alcohol, Glyceryl Stearate, Dimethicone, Filipendula Ulmaria Extract, Tocopherol, Xanthan Gum, Disodium EDTA, Sodium Hydroxide, Phenoxyethanol

Safety & Formulation Facts
✓ Pregnancy Safe ✓ Fragrance Free✓ Alcohol Free✗ Oil Free✗ Silicone Free✓ Paraben Free✓ Sulfate Free✓ Cruelty Free✗ Vegan✗ Fungal Acne Safe
Compatibility

Skin Match

Routine Step

moisturizer

Time of Day

AM & PM

Layering Tips

Apply to damp skin after bathing for maximum absorption. Use daily as a preventative measure for atopic-prone skin or more frequently during flares.

Results Timeline

Immediate: soft, comforted skin without tightness. Short-term (1-2 weeks): reduced itch and baseline dryness. Full benefits (4-8 weeks): noticeably fewer flare episodes with consistent daily use.

Pairs Well With
gentle syndet cleansersemollient bath oils
Planning a combo? Check it against what you already use
Sample AM Routine
  1. Gentle syndet cleanser
  2. THIS PRODUCT (body)
Sample PM Routine
  1. Bath or shower
  2. THIS PRODUCT (body, damp skin)
Evidence

Science & Expert Perspective

The Science

The evidence base for this cream is essentially the same as for the Exomega Control Balm, because the active ingredient set is identical. The defining study supporting the daily-emollient approach to atopic-prone skin is the 2014 trial published in the Journal of Allergy and Clinical Immunology, which followed high-risk infants for six months and documented a significantly reduced incidence of atopic dermatitis among those who received daily emollient application from early infancy. A 2017 Pediatric Dermatology review reinforced the finding and discussed the mechanisms: reduced transepidermal water loss, more intact barrier function, reduced frequency and severity of inflammatory flares.

The sunflower oil unsaponifiables in this formula are specifically chosen for their role in supporting the essential fatty acid composition of the stratum corneum lipid matrix. A 2018 paper in the International Journal of Molecular Sciences discussed the role of topical linoleic acid in activating PPAR-alpha and enhancing filaggrin expression in compromised skin — a mechanism that directly addresses one of the root metabolic problems in atopic dermatitis rather than just providing surface occlusion. Niacinamide's role in driving endogenous ceramide synthesis was documented in a 2005 British Journal of Dermatology paper showing improved barrier function and reduced transepidermal water loss after several weeks of topical use. And Rhealba oat extract has the Pierre Fabre-published research on anti-inflammatory marker modulation in reactive and compromised skin.

The texture choice — cream rather than balm — does not meaningfully affect the efficacy of these actives at the concentrations used. What the texture affects is adherence, which is the real determinant of clinical outcome in daily atopic skin management. A cream that's applied consistently twice a day will outperform a balm that's applied inconsistently, even if the balm is nominally more occlusive. This is the pragmatic logic behind offering the same active set in two different textures: matching the product to the real-world conditions of use is as important as matching it to the skin biology.

Dermatologist Perspective

Dermatologists commonly recommend the Exomega Control Cream as a daily maintenance emollient for atopic-prone children and adults, particularly in warmer climates or for users who find the balm variant too rich for daily use. Practicing dermatologists typically note that the active ingredient set is the same across the cream and balm, and that the choice between them is primarily a matter of texture preference and severity. The cream is typically recommended for twice-daily application to damp skin after bathing, as part of a routine that also includes a gentle syndet cleanser and any prescribed topical treatments. It is widely considered an appropriate supportive product for maintaining atopic-prone skin between flares.

Guidance

Usage & Recommendations

How to Use

Apply liberally to damp skin after bathing or showering, twice daily for atopic-prone skin maintenance. Use head to toe or on specific affected areas. During flares, more frequent application is appropriate. Pair with a gentle syndet cleanser or emollient bath oil to avoid stripping the skin. Safe to use alongside prescription eczema treatments — apply prescription topicals first, then the cream over top once they've absorbed.

Value Assessment

At roughly 26 dollars for 200ml, the Exomega Control Cream is priced slightly below the balm variant and comparably to other pharmacy-brand atopic body creams. A larger 400ml size is available in some markets and offers meaningfully better per-ml value for heavy daily users — families with multiple eczema-prone children should seek it out. The 200ml size lasts 4 to 6 weeks with daily full-body use. Compared to simpler drugstore eczema creams, the premium is justified by the specific Rhealba oat and sunflower oil unsaponifiables formulation, though budget-conscious users can achieve some of the basic emollient benefit with cheaper alternatives.

Who Should Buy

Adults and children with mild to moderate atopic-prone skin, people who find the Exomega Control balm too heavy for daily use, users in temperate or warm climates, and anyone building a preventative daily eczema routine.

Who Should Skip

Severely dry atopic skin that needs the full occlusive weight of a proper balm, users who are satisfied with drugstore alternatives, and those who want a non-prescription treatment for active eczema flares — this cream is a daily maintenance product, not an acute-phase treatment.

Ready to try A-Derma Exomega Control Emollient Cream?

Buy at Amazon
Details

Product Details

Texture

Medium cream with a soft, cushiony feel that absorbs in about a minute into a non-greasy finish.

Scent

Fragrance-free.

Packaging

Airless pump bottle; 200ml standard with larger 400ml option in some markets.

Finish
non-greasysatinlightweight
What to Expect on First Use

Feels lighter than the balm counterpart and absorbs faster, but still provides the comforted, cushioned feeling that atopic-prone skin needs. No tingling, no fragrance, no surprises. Fine for daily year-round use and better suited to summer than the balm.

How Long It Lasts

200ml lasts 4-6 weeks with daily full-body use.

Period After Opening

12 months

Opened yours? Track the toss-by date
Best Season

All Year

Certifications
cruelty-freefragrance-freeAFPADA recommended
Background

The Story Behind This Product

A-Derma developed the Exomega Control line to serve atopic-prone skin across ages and seasons. The cream and balm share the same core active ingredients in different emollient bases, letting users and pediatric dermatologists choose the appropriate texture based on severity and climate.

About A-Derma Legacy Brand (20+ years)

A-Derma's Exomega Control line is Pierre Fabre's dedicated atopic-prone skin range, carrying the AFPADA recommendation and widely recommended in European pediatric dermatology practice.

Brand founded: 1988 · Product launched: 2017
Myth vs. Reality

Common Myths

Myth

A lighter cream can't manage eczema-prone skin.

Reality

For mild to moderate atopic-prone skin, a well-formulated cream is often sufficient and more likely to be applied consistently than a heavier balm. Adherence matters more than absolute occlusion for long-term flare reduction.

Myth

All body moisturizers are the same for eczema.

Reality

The specific combination of lipid-replenishing actives, anti-inflammatory agents, and barrier-supporting ingredients matters. A simple glycerin-based body lotion is not equivalent to a formulation like this one.

FAQ

Frequently Asked Questions

Should I choose the Exomega Control Cream or the Balm?

Choose the cream for milder atopic-prone skin, year-round daily use, warmer climates, or when you want faster absorption. Choose the balm for severe dryness, cold weather, or when you need a more occlusive protective layer. The core active ingredient set is the same.

Can I use this cream on my child?

Yes. The Exomega Control line is commonly recommended by European pediatric dermatologists for atopic-prone children from infancy onward. Consult with your pediatrician for infants to confirm appropriate use.

How often should I apply it?

Daily or twice daily for atopic-prone skin maintenance, with more frequent application during flares or in particularly dry weather. Best applied to damp skin after bathing.

Can it replace prescription eczema treatment?

No. It's a daily preventative and supportive emollient. During active flares, prescription topicals are typically required. Use this cream alongside, not instead of, prescribed treatments.

Will it pill under clothing?

No. The cream absorbs into a non-greasy finish within about a minute and does not leave residue on clothing once absorbed. Give it a minute to sink in before dressing.

Is it suitable for keratosis pilaris?

Yes. The niacinamide and emollient base are helpful for the rough-bumpy texture of keratosis pilaris when used consistently. For more active KP treatment, pair with a urea or lactic acid product a few times a week.

How long does one pump bottle last?

A 200ml bottle lasts 4 to 6 weeks with daily full-body application. For heavy users, a 400ml size is available in some markets and offers better per-ml value.

Reviews

What Reviewers Tend to Say

Recurring themes our editors read across retailer reviews of this product — summaries in our words, not quotations, and not a substitute for your own patch test.

Common Praise

lighter than the balm but still effective

good for year-round use

fragrance-free with consistent results

safe for children and adults

Common Complaints

less intensive than the balm for severe dryness

standard drugstore-competitive pricing for pharmacy brand

limited US retail availability

Notable Endorsements
AFPADA atopic skin recommendationrecommended by European pediatric dermatologistswidely used in eczema-prone adult body routines